| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 96 | 2025 | 589 | 22.450 |
Why?
|
| Chromatin | 40 | 2025 | 479 | 9.360 |
Why?
|
| DNA-Binding Proteins | 38 | 2025 | 1445 | 8.330 |
Why?
|
| Histone Acetyltransferases | 20 | 2025 | 60 | 8.110 |
Why?
|
| Nucleosomes | 20 | 2025 | 137 | 6.620 |
Why?
|
| Protein Binding | 72 | 2025 | 2124 | 6.240 |
Why?
|
| Histone-Lysine N-Methyltransferase | 15 | 2025 | 124 | 5.750 |
Why?
|
| Lysine | 29 | 2023 | 286 | 5.640 |
Why?
|
| Epigenesis, Genetic | 23 | 2024 | 617 | 5.430 |
Why?
|
| Protein Processing, Post-Translational | 31 | 2022 | 457 | 5.420 |
Why?
|
| Protein Domains | 23 | 2025 | 256 | 5.330 |
Why?
|
| Transcription Factors | 30 | 2025 | 1647 | 5.150 |
Why?
|
| Nuclear Proteins | 16 | 2025 | 660 | 4.540 |
Why?
|
| Models, Molecular | 53 | 2025 | 1491 | 4.490 |
Why?
|
| PHD Zinc Fingers | 9 | 2024 | 13 | 4.290 |
Why?
|
| Saccharomyces cerevisiae Proteins | 14 | 2024 | 383 | 4.160 |
Why?
|
| Tumor Suppressor Proteins | 15 | 2025 | 314 | 3.440 |
Why?
|
| Protein Structure, Tertiary | 46 | 2017 | 843 | 3.340 |
Why?
|
| Acetylation | 31 | 2025 | 244 | 3.120 |
Why?
|
| Adenosine Triphosphatases | 6 | 2020 | 161 | 2.940 |
Why?
|
| Transcription Factor TFIID | 7 | 2024 | 24 | 2.930 |
Why?
|
| Binding Sites | 38 | 2024 | 1248 | 2.850 |
Why?
|
| Methylation | 35 | 2025 | 230 | 2.840 |
Why?
|
| Phosphatidylinositol Phosphates | 16 | 2011 | 39 | 2.630 |
Why?
|
| Homeodomain Proteins | 17 | 2024 | 494 | 2.450 |
Why?
|
| Crystallography, X-Ray | 24 | 2021 | 438 | 2.350 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 9 | 2017 | 26 | 2.320 |
Why?
|
| Repressor Proteins | 7 | 2025 | 406 | 2.260 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2023 | 156 | 2.140 |
Why?
|
| Histone Code | 10 | 2019 | 31 | 2.140 |
Why?
|
| DNA | 16 | 2025 | 1404 | 1.980 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 399 | 1.920 |
Why?
|
| Magnetic Resonance Spectroscopy | 20 | 2022 | 539 | 1.830 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2025 | 42 | 1.800 |
Why?
|
| Epigenomics | 3 | 2020 | 110 | 1.700 |
Why?
|
| Amino Acid Sequence | 32 | 2024 | 2057 | 1.690 |
Why?
|
| DNA Helicases | 5 | 2023 | 148 | 1.660 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2024 | 530 | 1.650 |
Why?
|
| DNA Methylation | 9 | 2024 | 611 | 1.650 |
Why?
|
| Protein Conformation | 21 | 2021 | 863 | 1.640 |
Why?
|
| Zinc Fingers | 6 | 2020 | 45 | 1.580 |
Why?
|
| Autophagy | 5 | 2022 | 266 | 1.460 |
Why?
|
| Humans | 135 | 2025 | 129625 | 1.460 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2025 | 116 | 1.450 |
Why?
|
| HEK293 Cells | 13 | 2024 | 698 | 1.380 |
Why?
|
| Protein Interaction Domains and Motifs | 10 | 2020 | 139 | 1.360 |
Why?
|
| Mitosis | 3 | 2017 | 180 | 1.350 |
Why?
|
| Embryonic Stem Cells | 3 | 2025 | 114 | 1.230 |
Why?
|
| Translocation, Genetic | 4 | 2023 | 96 | 1.170 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 18 | 2021 | 260 | 1.160 |
Why?
|
| Phosphatidylinositols | 7 | 2012 | 57 | 1.160 |
Why?
|
| Molecular Sequence Data | 25 | 2015 | 2835 | 1.150 |
Why?
|
| Cell Cycle Proteins | 8 | 2022 | 584 | 1.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 2 | 2025 | 14 | 1.130 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 507 | 1.120 |
Why?
|
| Mutation | 12 | 2025 | 3717 | 1.110 |
Why?
|
| Polycomb-Group Proteins | 7 | 2023 | 28 | 1.080 |
Why?
|
| Multiprotein Complexes | 3 | 2018 | 155 | 1.060 |
Why?
|
| Drug Design | 2 | 2020 | 158 | 1.050 |
Why?
|
| Sequestosome-1 Protein | 4 | 2022 | 13 | 1.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2024 | 18 | 1.010 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2018 | 63 | 0.990 |
Why?
|
| Membrane Proteins | 11 | 2012 | 1125 | 0.980 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 340 | 0.970 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 334 | 0.970 |
Why?
|
| Animals | 44 | 2025 | 35391 | 0.970 |
Why?
|
| Gene Silencing | 2 | 2025 | 190 | 0.950 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2022 | 100 | 0.950 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2025 | 30 | 0.950 |
Why?
|
| Calixarenes | 2 | 2015 | 5 | 0.940 |
Why?
|
| Gene Expression Regulation | 12 | 2023 | 2542 | 0.940 |
Why?
|
| Endogenous Retroviruses | 1 | 2025 | 34 | 0.920 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2021 | 8 | 0.910 |
Why?
|
| Ubiquitin | 2 | 2022 | 64 | 0.900 |
Why?
|
| Drosophila Proteins | 3 | 2017 | 185 | 0.890 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 441 | 0.880 |
Why?
|
| Dioxygenases | 1 | 2024 | 28 | 0.880 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2025 | 20 | 0.880 |
Why?
|
| SUMO-1 Protein | 2 | 2020 | 20 | 0.860 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2023 | 45 | 0.840 |
Why?
|
| Heterochromatin | 3 | 2025 | 43 | 0.820 |
Why?
|
| Acetyltransferases | 1 | 2023 | 21 | 0.820 |
Why?
|
| DNA Replication | 2 | 2023 | 227 | 0.820 |
Why?
|
| Thiazoles | 1 | 2023 | 117 | 0.820 |
Why?
|
| Diet | 2 | 2022 | 1213 | 0.810 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 3 | 2018 | 13 | 0.810 |
Why?
|
| Polyphenols | 1 | 2022 | 18 | 0.800 |
Why?
|
| Proteins | 4 | 2020 | 944 | 0.800 |
Why?
|
| Leukemia | 2 | 2023 | 229 | 0.800 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 70 | 0.780 |
Why?
|
| Cell Nucleus | 3 | 2023 | 584 | 0.780 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2020 | 58 | 0.770 |
Why?
|
| DNA Repair | 7 | 2024 | 210 | 0.750 |
Why?
|
| Histidine | 7 | 2017 | 60 | 0.740 |
Why?
|
| Acute Disease | 2 | 2021 | 979 | 0.730 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2011 | 217 | 0.730 |
Why?
|
| Mice | 21 | 2025 | 16961 | 0.710 |
Why?
|
| Betacoronavirus | 2 | 2020 | 250 | 0.700 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2020 | 3 | 0.700 |
Why?
|
| Vesicular Transport Proteins | 9 | 2009 | 84 | 0.690 |
Why?
|
| Biochemistry | 1 | 2020 | 38 | 0.680 |
Why?
|
| Oligopeptides | 1 | 2022 | 258 | 0.680 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2020 | 36 | 0.680 |
Why?
|
| Leukemia, Myeloid | 1 | 2020 | 45 | 0.680 |
Why?
|
| Immune Evasion | 1 | 2020 | 56 | 0.670 |
Why?
|
| Macromolecular Substances | 1 | 2020 | 216 | 0.670 |
Why?
|
| Enzymes | 1 | 2020 | 65 | 0.670 |
Why?
|
| Phase Transition | 1 | 2019 | 24 | 0.660 |
Why?
|
| Transcription, Genetic | 11 | 2024 | 1418 | 0.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1336 | 0.650 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 2046 | 0.650 |
Why?
|
| Immunity, Innate | 2 | 2022 | 805 | 0.640 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 3186 | 0.640 |
Why?
|
| Membrane Lipids | 3 | 2012 | 91 | 0.640 |
Why?
|
| Antiviral Agents | 3 | 2024 | 715 | 0.630 |
Why?
|
| Viral Vaccines | 1 | 2020 | 94 | 0.630 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 109 | 0.620 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2020 | 163 | 0.620 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 43 | 0.620 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2020 | 60 | 0.620 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2020 | 201 | 0.620 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 596 | 0.610 |
Why?
|
| Neoplasms | 7 | 2024 | 2455 | 0.590 |
Why?
|
| Protein Structure, Secondary | 5 | 2013 | 341 | 0.570 |
Why?
|
| Promoter Regions, Genetic | 9 | 2025 | 1207 | 0.570 |
Why?
|
| Histone Deacetylases | 3 | 2016 | 212 | 0.560 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 749 | 0.560 |
Why?
|
| Ligands | 5 | 2021 | 621 | 0.550 |
Why?
|
| Pyrans | 1 | 2017 | 5 | 0.550 |
Why?
|
| Antigens, Neoplasm | 2 | 2016 | 308 | 0.540 |
Why?
|
| Cell Plasticity | 1 | 2017 | 27 | 0.540 |
Why?
|
| Mutagenesis, Site-Directed | 10 | 2021 | 361 | 0.530 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 42 | 0.530 |
Why?
|
| Histidine Kinase | 1 | 2016 | 34 | 0.520 |
Why?
|
| Protein Folding | 4 | 2017 | 265 | 0.520 |
Why?
|
| Molecular Dynamics Simulation | 5 | 2020 | 217 | 0.520 |
Why?
|
| Structure-Activity Relationship | 5 | 2025 | 545 | 0.510 |
Why?
|
| Morpholines | 1 | 2017 | 122 | 0.510 |
Why?
|
| Thiophenes | 1 | 2017 | 117 | 0.510 |
Why?
|
| Autoantigens | 4 | 2014 | 420 | 0.510 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 419 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 131 | 0.490 |
Why?
|
| Molecular Structure | 7 | 2021 | 481 | 0.490 |
Why?
|
| Cell Membrane | 4 | 2012 | 734 | 0.490 |
Why?
|
| Inositol Phosphates | 2 | 2012 | 22 | 0.480 |
Why?
|
| Fluorescence Polarization | 3 | 2021 | 38 | 0.480 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2023 | 887 | 0.480 |
Why?
|
| Pandemics | 2 | 2020 | 1491 | 0.480 |
Why?
|
| Carrier Proteins | 2 | 2018 | 745 | 0.480 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 2 | 2021 | 5 | 0.470 |
Why?
|
| Plant Proteins | 1 | 2015 | 89 | 0.470 |
Why?
|
| Signal Transduction | 9 | 2024 | 4931 | 0.460 |
Why?
|
| Lipid Bilayers | 4 | 2011 | 97 | 0.460 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1164 | 0.460 |
Why?
|
| Phosphorylation | 7 | 2016 | 1713 | 0.450 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 611 | 0.450 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 109 | 0.440 |
Why?
|
| Protein Subunits | 4 | 2024 | 233 | 0.440 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2018 | 372 | 0.430 |
Why?
|
| Intracellular Membranes | 3 | 2011 | 83 | 0.410 |
Why?
|
| Molecular Docking Simulation | 3 | 2020 | 109 | 0.410 |
Why?
|
| Influenza, Human | 1 | 2019 | 601 | 0.410 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 67 | 0.390 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1891 | 0.380 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2017 | 541 | 0.380 |
Why?
|
| Cyclophilins | 2 | 2023 | 41 | 0.380 |
Why?
|
| Micelles | 4 | 2006 | 37 | 0.380 |
Why?
|
| HMGN2 Protein | 1 | 2011 | 3 | 0.370 |
Why?
|
| Molecular Probes | 1 | 2011 | 36 | 0.370 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 1308 | 0.370 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2011 | 3 | 0.370 |
Why?
|
| Static Electricity | 4 | 2020 | 116 | 0.360 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 13 | 0.360 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 361 | 0.350 |
Why?
|
| Molecular Conformation | 2 | 2022 | 141 | 0.350 |
Why?
|
| Sequence Alignment | 8 | 2015 | 332 | 0.350 |
Why?
|
| Cell Line | 10 | 2024 | 2784 | 0.350 |
Why?
|
| Qc-SNARE Proteins | 3 | 2006 | 7 | 0.340 |
Why?
|
| RNA | 2 | 2023 | 882 | 0.340 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2020 | 651 | 0.340 |
Why?
|
| CpG Islands | 2 | 2023 | 152 | 0.330 |
Why?
|
| Protein Multimerization | 3 | 2024 | 179 | 0.330 |
Why?
|
| Viral Proteins | 2 | 2022 | 327 | 0.330 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 38 | 0.320 |
Why?
|
| Models, Biological | 7 | 2020 | 1724 | 0.320 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2021 | 36 | 0.320 |
Why?
|
| Acylation | 2 | 2019 | 28 | 0.320 |
Why?
|
| Peptides | 6 | 2020 | 926 | 0.310 |
Why?
|
| Catalytic Domain | 3 | 2019 | 220 | 0.310 |
Why?
|
| Conserved Sequence | 5 | 2013 | 227 | 0.300 |
Why?
|
| Amino Acid Motifs | 8 | 2020 | 215 | 0.300 |
Why?
|
| Escherichia coli | 4 | 2020 | 767 | 0.290 |
Why?
|
| Ubiquitination | 2 | 2019 | 98 | 0.290 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2007 | 31 | 0.290 |
Why?
|
| Carcinogenesis | 2 | 2021 | 213 | 0.290 |
Why?
|
| Kinetics | 3 | 2020 | 1645 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 569 | 0.280 |
Why?
|
| Genetic Therapy | 1 | 2009 | 289 | 0.280 |
Why?
|
| HeLa Cells | 7 | 2017 | 612 | 0.280 |
Why?
|
| Small Molecule Libraries | 2 | 2021 | 86 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 326 | 0.280 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 4 | 2015 | 183 | 0.280 |
Why?
|
| Apoptosis | 3 | 2023 | 2492 | 0.280 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2007 | 44 | 0.280 |
Why?
|
| CREB-Binding Protein | 2 | 2019 | 27 | 0.280 |
Why?
|
| Methyltransferases | 2 | 2019 | 70 | 0.270 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 21 | 0.260 |
Why?
|
| Cell Cycle | 2 | 2020 | 588 | 0.250 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 24 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 808 | 0.250 |
Why?
|
| Substrate Specificity | 7 | 2013 | 371 | 0.250 |
Why?
|
| Crystallization | 2 | 2020 | 137 | 0.240 |
Why?
|
| Cytosol | 2 | 2021 | 219 | 0.240 |
Why?
|
| HCT116 Cells | 1 | 2025 | 78 | 0.230 |
Why?
|
| Tryptophan | 3 | 2020 | 177 | 0.230 |
Why?
|
| DNA Damage | 4 | 2015 | 384 | 0.230 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2025 | 29 | 0.230 |
Why?
|
| Virus Replication | 2 | 2024 | 452 | 0.220 |
Why?
|
| Endosomes | 2 | 2005 | 126 | 0.220 |
Why?
|
| Cloning, Molecular | 2 | 2020 | 525 | 0.220 |
Why?
|
| Phosphatidylethanolamines | 3 | 2011 | 74 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2023 | 19 | 0.210 |
Why?
|
| Tudor Domain | 3 | 2021 | 3 | 0.210 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 53 | 0.210 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2023 | 48 | 0.210 |
Why?
|
| Homologous Recombination | 1 | 2023 | 23 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2021 | 4084 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2024 | 636 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 176 | 0.200 |
Why?
|
| Biophysical Phenomena | 2 | 2021 | 64 | 0.200 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 210 | 0.200 |
Why?
|
| Plants | 2 | 2023 | 218 | 0.200 |
Why?
|
| Databases, Protein | 1 | 2021 | 61 | 0.190 |
Why?
|
| Peptidomimetics | 1 | 2021 | 3 | 0.180 |
Why?
|
| K562 Cells | 2 | 2019 | 85 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 149 | 0.180 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 190 | 0.180 |
Why?
|
| Zinc Finger Nucleases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2020 | 3 | 0.180 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2020 | 4 | 0.180 |
Why?
|
| GATA4 Transcription Factor | 1 | 2020 | 18 | 0.180 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2021 | 84 | 0.180 |
Why?
|
| Buffers | 1 | 2020 | 56 | 0.180 |
Why?
|
| Chemical Fractionation | 1 | 2020 | 29 | 0.170 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.170 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2020 | 3 | 0.170 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 15 | 0.170 |
Why?
|
| Antigens, Nuclear | 1 | 2020 | 20 | 0.170 |
Why?
|
| Disulfiram | 1 | 2020 | 14 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 191 | 0.170 |
Why?
|
| Phosphoproteins | 3 | 2016 | 335 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2021 | 130 | 0.170 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 67 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 53 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 68 | 0.170 |
Why?
|
| Fluorescence | 1 | 2020 | 155 | 0.170 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 89 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2881 | 0.160 |
Why?
|
| Phosphatidylcholines | 2 | 2011 | 145 | 0.160 |
Why?
|
| Protein Transport | 5 | 2005 | 429 | 0.160 |
Why?
|
| E2F1 Transcription Factor | 1 | 2019 | 61 | 0.160 |
Why?
|
| Virulence | 1 | 2020 | 255 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 37 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 2011 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2373 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 285 | 0.160 |
Why?
|
| Synaptosomal-Associated Protein 25 | 4 | 2006 | 26 | 0.160 |
Why?
|
| Genetic Vectors | 1 | 2020 | 314 | 0.150 |
Why?
|
| Binding, Competitive | 1 | 2019 | 206 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 109 | 0.150 |
Why?
|
| Drosophila | 2 | 2017 | 141 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 2342 | 0.150 |
Why?
|
| Sumoylation | 1 | 2018 | 16 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 132 | 0.150 |
Why?
|
| Life Expectancy | 1 | 2018 | 60 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 460 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 119 | 0.140 |
Why?
|
| Catalysis | 1 | 2019 | 310 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 221 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 3 | 2010 | 55 | 0.140 |
Why?
|
| Xenopus | 1 | 2017 | 85 | 0.140 |
Why?
|
| Cell Survival | 2 | 2021 | 1076 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2019 | 813 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 318 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2018 | 452 | 0.130 |
Why?
|
| Arginine | 2 | 2023 | 263 | 0.130 |
Why?
|
| Aspartic Acid | 1 | 2016 | 80 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 367 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 499 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 1049 | 0.130 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 149 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 157 | 0.130 |
Why?
|
| Life Style | 1 | 2018 | 461 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 824 | 0.120 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 102 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2017 | 151 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2016 | 107 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 388 | 0.120 |
Why?
|
| Gene Expression | 1 | 2020 | 1465 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 162 | 0.120 |
Why?
|
| Human papillomavirus 18 | 1 | 2015 | 15 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 68 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 192 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2017 | 682 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 109 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 387 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 34 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 130 | 0.120 |
Why?
|
| Leucine | 2 | 2024 | 109 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 359 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 714 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1159 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 88 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2016 | 234 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1685 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2014 | 62 | 0.110 |
Why?
|
| Algorithms | 1 | 2021 | 1616 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2128 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 269 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1843 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 840 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 2133 | 0.100 |
Why?
|
| Dimerization | 2 | 2006 | 192 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4078 | 0.100 |
Why?
|
| Spindle Apparatus | 1 | 2013 | 94 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 182 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 230 | 0.100 |
Why?
|
| Eukaryota | 1 | 2012 | 55 | 0.090 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 175 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2011 | 181 | 0.080 |
Why?
|
| Escherichia coli Proteins | 2 | 2003 | 179 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2014 | 693 | 0.080 |
Why?
|
| Down Syndrome | 1 | 2016 | 477 | 0.080 |
Why?
|
| Phospholipids | 1 | 2011 | 216 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 122 | 0.080 |
Why?
|
| Biological Transport | 1 | 2011 | 404 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 231 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 278 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 880 | 0.080 |
Why?
|
| SNARE Proteins | 2 | 2006 | 39 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 176 | 0.080 |
Why?
|
| Inhibitor of Growth Protein 1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2012 | 404 | 0.070 |
Why?
|
| Nitrogen Isotopes | 1 | 2008 | 58 | 0.070 |
Why?
|
| Pyridines | 1 | 2012 | 478 | 0.070 |
Why?
|
| VDJ Recombinases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2007 | 7 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 56 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 88 | 0.070 |
Why?
|
| Protons | 1 | 2008 | 81 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2008 | 126 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2012 | 607 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 186 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2020 | 226 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2006 | 6 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 81 | 0.060 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.060 |
Why?
|
| Phosphopeptides | 1 | 2006 | 18 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 333 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2006 | 37 | 0.060 |
Why?
|
| Spin Labels | 1 | 2005 | 46 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 269 | 0.060 |
Why?
|
| Mathematics | 1 | 2005 | 102 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 948 | 0.060 |
Why?
|
| Hydroxylamines | 1 | 2024 | 3 | 0.060 |
Why?
|
| Pyridones | 1 | 2006 | 158 | 0.060 |
Why?
|
| Cytidine | 1 | 2024 | 6 | 0.060 |
Why?
|
| Vero Cells | 1 | 2024 | 66 | 0.060 |
Why?
|
| Neutrophils | 1 | 2010 | 1210 | 0.060 |
Why?
|
| Virus Internalization | 1 | 2024 | 47 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 45 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2019 | 393 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 30 | 0.050 |
Why?
|
| Symporters | 1 | 2003 | 56 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 25 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2023 | 18 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 20 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2024 | 370 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 915 | 0.050 |
Why?
|
| Liposomes | 2 | 2007 | 171 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 14 | 0.050 |
Why?
|
| Stress Fibers | 1 | 2002 | 18 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2020 | 953 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 627 | 0.050 |
Why?
|
| Serine | 1 | 2023 | 138 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2001 | 3 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 126 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 42 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2001 | 130 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 118 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 137 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2020 | 38 | 0.040 |
Why?
|
| Actins | 1 | 2002 | 411 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 431 | 0.040 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2019 | 2 | 0.040 |
Why?
|
| DNA, Superhelical | 1 | 1999 | 11 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 591 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 61 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 136 | 0.040 |
Why?
|
| Structural Homology, Protein | 2 | 2011 | 25 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 327 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 53 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 110 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 76 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 398 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 329 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 232 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 5483 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 1999 | 321 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 627 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 19 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 272 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1999 | 323 | 0.030 |
Why?
|
| Female | 4 | 2017 | 68734 | 0.030 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 71 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 2010 | 98 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Zinc | 1 | 1999 | 285 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 50 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 114 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 133 | 0.030 |
Why?
|
| Locus Control Region | 1 | 2015 | 2 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 376 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 329 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 153 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 639 | 0.030 |
Why?
|
| Prophase | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 4 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 374 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 65 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1087 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 55 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 949 | 0.030 |
Why?
|
| Base Sequence | 2 | 2012 | 2147 | 0.030 |
Why?
|
| CD79 Antigens | 1 | 2012 | 15 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 140 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 14 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 487 | 0.020 |
Why?
|
| Receptors, Antigen | 1 | 2012 | 15 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 15 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2012 | 54 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 60 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 168 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 259 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 275 | 0.020 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 5455 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 117 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 182 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 84 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2011 | 318 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3968 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 873 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 161 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 466 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 596 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 977 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2007 | 64 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 816 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 752 | 0.020 |
Why?
|
| Metabolomics | 1 | 2012 | 653 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 26 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 1494 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 1055 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 224 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 78 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2627 | 0.010 |
Why?
|
| Solutions | 1 | 2003 | 150 | 0.010 |
Why?
|
| Dishevelled Proteins | 1 | 2002 | 3 | 0.010 |
Why?
|
| Axin Protein | 1 | 2002 | 19 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 35 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 154 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 279 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 438 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 179 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2002 | 167 | 0.010 |
Why?
|
| Vacuoles | 1 | 2001 | 36 | 0.010 |
Why?
|
| Propanolamines | 1 | 2001 | 97 | 0.010 |
Why?
|
| Factor For Inversion Stimulation Protein | 1 | 1999 | 1 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1999 | 13 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1999 | 33 | 0.010 |
Why?
|
| DNA Gyrase | 1 | 1999 | 12 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 201 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1999 | 43 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 399 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1999 | 54 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2001 | 423 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 1206 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 3075 | 0.010 |
Why?
|
| Male | 1 | 2014 | 63670 | 0.000 |
Why?
|